Journals

The American Academy of Neurology (AAN) Annual Meeting 2026 delivered new data and practical insights across neurology. Explore key…

Evidence from the innovatively designed ARASEC trial, showing significant PFS and OS improvement with darolutamide plus ADT versus ADT alone…

This article provides an update on the treatment of Clostridioides difficile infection (CDI), combining key recent data with perspectives…

AAD 2026 brought new perspectives across clinical practice, research, and innovation. In this issue, we highlight key meeting themes…

Two leading experts discuss the COVID-19 post-exposure prevention gap, especially in high-contact and group care settings among vulnerable…

Catch up on selected 2025-2026 conference data across AD, CHE, GPP, and PG, including symptom burden, long-term disease impact, and…

Chronic hepatitis B affects approximately 1.7 million people in the United States and represents a significant public health challenge…

COPD remains one of the leading causes of morbidity and mortality in the USA, contributing to thousands of emergency visits…